Package 0527-6011-06

Brand: fluticasone propionate and salmeterol

Generic: fluticasone propionate and salmeterol
NDC Package

Package Facts

Identity

Package NDC 0527-6011-06
Digits Only 0527601106
Product NDC 0527-6011
Description

1 INHALER in 1 CARTON (0527-6011-06) / 60 POWDER in 1 INHALER

Marketing

Marketing Status
Marketed Since 2026-01-12
Brand fluticasone propionate and salmeterol
Generic fluticasone propionate and salmeterol
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "efbe29ce-a9b0-4b50-85df-780d8050315c", "openfda": {"unii": ["6EW8Q962A5", "O2GMZ0LF5W"], "rxcui": ["896184", "896209"], "spl_set_id": ["9c1680db-16e9-4658-977b-110631f95a65"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INHALER in 1 CARTON (0527-6011-06)  / 60 POWDER in 1 INHALER", "package_ndc": "0527-6011-06", "marketing_start_date": "20260112"}], "brand_name": "Fluticasone Propionate and Salmeterol", "product_id": "0527-6011_efbe29ce-a9b0-4b50-85df-780d8050315c", "dosage_form": "POWDER", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "0527-6011", "generic_name": "fluticasone propionate and salmeterol", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluticasone Propionate and Salmeterol", "active_ingredients": [{"name": "FLUTICASONE PROPIONATE", "strength": "250 ug/1"}, {"name": "SALMETEROL XINAFOATE", "strength": "50 ug/1"}], "application_number": "ANDA214464", "marketing_category": "ANDA", "marketing_start_date": "20241129", "listing_expiration_date": "20271231"}